Man Group plc Takes Position in OraSure Technologies, Inc. $OSUR

Man Group plc bought a new position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 150,854 shares of the medical instruments supplier’s stock, valued at approximately $673,000.

A number of other institutional investors and hedge funds have also bought and sold shares of OSUR. Quadrature Capital Ltd bought a new position in OraSure Technologies in the 4th quarter valued at about $28,000. Legal & General Group Plc acquired a new position in shares of OraSure Technologies in the second quarter valued at approximately $30,000. Prudential Financial Inc. acquired a new position in shares of OraSure Technologies in the second quarter valued at approximately $31,000. Diversify Wealth Management LLC bought a new position in shares of OraSure Technologies during the first quarter worth approximately $36,000. Finally, Diversify Advisory Services LLC acquired a new stake in OraSure Technologies during the 2nd quarter worth approximately $47,000. Institutional investors and hedge funds own 93.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on OSUR shares. Weiss Ratings restated a “sell (d-)” rating on shares of OraSure Technologies in a research note on Tuesday. Wall Street Zen raised OraSure Technologies from a “sell” rating to a “hold” rating in a report on Monday, August 10th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus target price of $3.00.

OraSure Technologies Stock Down 0.8%

OSUR stock opened at $3.58 on Friday. OraSure Technologies, Inc. has a 12 month low of $2.08 and a 12 month high of $4.58. The firm has a market cap of $246.91 million, a P/E ratio of -5.19 and a beta of 0.99. The company’s 50-day moving average price is $4.00 and its two-hundred day moving average price is $3.56.

About OraSure Technologies

OraSure Technologies, Inc is a Bethlehem, Pennsylvania–based diagnostic and medical device company specializing in the development, manufacture and commercialization of point-of-care and self-testing products. Founded in 1988, OraSure has built a portfolio of oral fluid and other non-invasive specimen collection technologies that support the detection of infectious diseases, drugs of abuse, and health and wellness biomarkers.

The company’s flagship product, the OraQuick® rapid HIV test, was the first Food and Drug Administration–approved over-the-counter oral fluid test for the detection of HIV-1/2 antibodies.